ImmunoGen surges after cancer drug study hits ‘home run’ – Reuters

Leave a Comment / Business / By
  1. ImmunoGen surges after cancer drug study hits ‘home run’Reuters
  2. ELAHERE® Demonstrates Overall Survival Benefit in Phase 3 MIRASOL Trial in Patients With Platinum-Resistant FRα-Positive Ovarian CancerImmunoGen, Inc.
  3. ImmunoGen touts additional positive data on ovarian cancer drug, seeks expanded use approval, stock soarsYahoo finance
  4. ImmunoGen’s Elahere Achieves Historic Victory in Ovarian CancerFiercePharma
  5. ImmunoGen Touts Additional Positive Ovarian Cancer Drug Data, Seeks Expanded-Use Approval, Stock SoaGasoline

Leave a Comment

Your email address will not be published. Required fields are marked *